C&EN’s tabulation follows approvals from the FDA’s Center for ... new class of antischizophrenia drug to be approved in decades. Roughly one-third of last year’s new drugs were for oncology ...
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...
The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine ... oxycodone and fentanyl each year for pain. Nearly 108,000 people died from drug overdoses in 2022, with approximately ...
On Thursday, the Food and Drug Administration (FDA ... receive prescriptions for moderate-to-severe acute pain each year. The FDA's approval process for Journavx included an evaluation of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results